Aktories, K.; Wegner, A., 1989.ADP-ribosylation of actin by clostridial toxins. J Cell Biol 109, 1385–1387.
Aziminia, P., Pilehchian-Langroudi, R., Esmaeilnia, K., 2016. Cloning and expression of Clostridium perfringens type D vaccine strain epsilon toxin gene in E. coli as a recombinant vaccine candidate. Iranian J Microbiol 8, 226-231.
Bakhshi, F., Pilehchian-Langroudi, R., Golestani, Eimani, B., 2016. Enhanced expression of recombinant beta toxin of Clostridium perfringens type B using a commercially available Escherichia coli strain. Onderstepoort J Vet Res 30; 83(1):a1136.
Barth, H., Aktories, K., Popoff, M.R., Stiles, B.G., 2004. Binary bacterial toxins: Biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiol. Mol Biol Rev 68, 373–402.
Barth, H., K. Aktories, M. R. Popoff, and B. G. Stiles. 2004. Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiol. Mol Biol Rev 68:373–402.
Blöcker, D., Behlke, J., Aktories, K., Barth, H., 2001. Cellular uptake of the Clostridium perfringens binary iota-toxin. Infect Immun 69(5):2980-7.
Brynestad, S., Synstad, B., Granum, P.E., 1997.Th e Clostridiumperfringensenterotoxin gene is on a transposable element in type A human food poisoning strains. Microbiology 143: 2109-2115.
Czeczulin, J.R., Collie, R.E., McClane, B.A., 1996. Regulated expression of Clostridium perfringens enterotoxin in naturally cpe-negative type A, B, and C isolates of C. perfringens. Infec Immun 64: 3301-3309.
Hale, M. L., J. C. Marvaud, M. R. Popoff, and B. G. Stiles. 2004. Detergentresistant membrane microdomains facilitate Ib oligomer formation and biological activity of Clostridium perfringens iota-toxin. Infect Immun 72: 2186–2193.
McDonel, J.L., 1986. Pharmacology of Bacterial Toxins; Pergamon Press: New York, NY, USA, pp. 477–517.
Ming-Yi Zhou and Celso E. Gomez-Sanchez., 2000.Universal TA Cloning.Curr. Mol Biol 2(1): 1-7.
Nagahama, M., Umezaki, M., Oda, M., Kobayashi, K., Tone, S, Suda, T., Ishidoh, K., Sakurai, J., 2011. Clostridium perfringens iota-toxin binducesrapidcellnecrosis. Infect Immun 79(11):4353-60.
Nijland R, Lindner C, Hartskamp M, Hamoen L, Kuipers OP., 2007 Heterologous production and secretion of Clostridium perfringens β-toxoid in closelyrelated Gram-positive hosts. J Biotechnol 127:361-372.
Perelle S, Scalzo S, Kochi S, Mock M, Popoff MR., 1997. Immunological and functional comparison between Clostridium perfringens iota toxin, C. spiroforme toxin, and anthrax toxins. FEMS Microbiol Lett 146(1):117-21.
Petit, L., Gibert, M., Popoff, M.R., 1999. Clostridium perfringens: toxinotype and genotype. Trends. Microbiol 7: 104-110.
PilehchianLangroudi R, Shamsara M, Aghaiypour K., 2013. Expression of Clostridium perfringens epsilon-beta fusion toxin gene in E. coli and its immunologic studies in mouse.Vaccine 11; 31 (32):3295-9.
PilehchianLangroudi R., 2015. Isolation, Specification, Molecular Biology Assessment and Vaccine Development of Clostridium in Iran: A Review. Int J Enteric Pathog 3(4): e28979.
Sakurai J, Nagahama M, Oda M, Tsuge H, Kobayashi K., 2009. Clostridium perfringens iota-toxin: structure and function. Toxins (Basel) 1(2):208-28.
Sakurai, J., Nagahama. M., Ochi, S., 1997.Major toxins of Clostridium perfringens. J Toxicol Toxin Rev 16, 195–214.
Stiles BG, Hale ML, Marvaud JC, Popoff MR., 2002. Clostridium perfringens iotatoxin: characterization of the cell-associatediotab complex. Biochem J 367(Pt 3):801-8.
Vandekerckhove J, Schering B, Bärmann M, Aktories K., 1987. Clostridium perfringens iota toxin ADP-ribosylates skeletal muscle actin in Arg-177.FEBS Lett 225(1-2):48-52.
Hadjeb, N. and Berkowitz, G.A., 1996. Preparation of T-overhang vectors with high PCR product cloning efficiency. BioTechniques 20: 20-22.
Rashtchian, A., 1995. Novel methods for cloning and engineering genes using the polymerase chain reaction. Curr Opin Biotech 6: 30-36.